103
Views
31
CrossRef citations to date
0
Altmetric
Original

Hydroxyl radical modification of human serum albumin generated cross reactive antibodies

, , &
Pages 479-488 | Published online: 07 Jul 2009

References

  • Shacter E. Quantification and significance of protein oxidation in biological samples. Drug Metab Rev 2000; 32: 307–326
  • Poon HF, Vaishnav RA, Gelchell TV, Getchell ML, Butterfield DA. Quantitative proteomics analysis of differential protein expression and oxidative modification of specific proteins in the brains of old mice. Neurobiol Aging 2006; 27: 1010–1019
  • Tabner BJ, Turnbull S, El-Agnaf O, Allsop D. Production of reaction oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative disease. Curr Top Med Chem 2001; 1: 507–517
  • Arutyunova EI, Danshina PV, Domnina LV, Pleten AP, Muronetz VI. Oxidation of glyceraldehydes-3-phosphate dehydrogenase enhances its binding to nucleic acids. Biochem Biophys Res Commun 2003; 307: 547–552
  • Shacter E, Williams JA, Levine RL. Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation. Free Radic Biol Med 1995; 18: 815–821
  • Chou C. Binding of rheumatoid and lupus synovial fluids and sera-derived human IgG rheumatoid factor to degalactosylated IgG. Arch Med Res 2002; 33: 541–544
  • Holvoet P, Collen D. Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis. Atherosclerosis 1998; 137: S33–S38
  • Chiu-Braga YY, Hayashi SY, Schafranski M, Messias-Reason IJT. Further evidence of inflammation in chronic rheumatic valve disease (CRVD): High levels of advanced oxidation protein product (AOPP) and high sensitive C-reactive protein (hs-CRP). Int J Cardiol 2006, in press
  • Scofield RH, Kurien BT, Ganick S, McClain MT, Pye Q, James JA, Schneider RI, Broyles RH, Bachmann M, Hensley K. Modification of lupus-associated 60-KDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radic Biol Med 2005; 38: 719–728
  • Eggleton P. Stress protein-polypeptide complexes acting as autoimmune triggers. Clin Exp Immunol 2003; 134: 6–8
  • Ahsan H, Ali A, Ali R. Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol 2003; 131: 398–404
  • Mansoor F, Ali A, Ali R. Binding of circulating SLE autoantibodies to oxygen free radical damaged chromatin. Autoimmunity 2005; 38: 431–438
  • Habib S, Moinuddin Ali R. Acquired antigenicity of DNA after modification with peroxynitrite. Int J Biol Macromol 2005; 35: 221–225
  • Dixit K, Moinuddin Ali A. Immunological studies on peroxynitrite modifies human DNA. Life Sci 2005; 77: 2626–2642
  • Dixit K, Ali R. Antigen binding characteristics of antibodies induced against nitric oxide modified plasmid DNA. Biochim Biophys Acta 2001; 1528: 1–8
  • Fabisiak JP, Sedlov A, Kagan VE. Quantification of oxidative/nitrosative modification of CYS (34) in human serum albumin using a fluorescence-based SDS-PAGE assay. Antioxid Redox Signal 2002; 4: 855–865
  • Carballal S, Radi R, Kirk MC, Barnes S, Freeman BA, Alvarez B. Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite. Biochemistry 2003; 42: 9906–9914
  • Anraku M, Yamasaki K, Maruyama T, Kragh-Hansen U, Otagiri M. Effect of oxidative stress on the structure and function of human serum albumin. Pharm Res 2001; 18: 632–639
  • Davies KJA. Protein damage and degradation by oxygen radicals. J Biol Chem 1987; 262: 9895–9901
  • Oettl K, Hallstrom S, Jurcens G, Fuchs D, Blomster H, Schmut O, Sudi K, Greilberger J. Reduced and oxidized forms of human serum albumin in sports, aging and disease. FEBS J 2005; 271: H3–030P
  • Rigamonti C, Mottaran E, Reale E, Rolla R, Cipriani V, Capelli F, Boldarini R, Vidali M, Sartori M, Albano E. Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C. Hepatology 2003; 38: 42–49
  • Jain SK, Pemberton PW, Smit A, McMohan RF, Burrows PC, Aboutwerat A, Warnes TW. Oxidative stress in chronic hepatitis C: Not just a feature of late stage disease. J Hepatol 2002; 36: 805–811
  • Era S, Kuwata K, Imai H, Nakamura K, Hayaski T, Sogami M. Age-related change in redox state of human serum albumin. Biochim Biophys Acta 1995; 1247: 12–16
  • Suzuki E, Yasuda K, Takeda N, Sakata S, Era S, Kuwata K, Sogami M, Miura K. Increased oxidized form of human serum albumin in patients with diabetes mellitus. Diabetes Res Clin Pract 1992; 18: 153–158
  • Mera K, Anraku M, Kitamura K, Nakajou K, Maruyama T, Otagiri M. The structure and function of oxidized albumin in hemodialysis patients: Its role in elevated oxidative stress via neutrophil burst. Biochem Biophys Res Commun 2005; 334: 1322–1328
  • Soejima A, Matsuzawa N, Hayashi T, Kimura R, Ootsuka T, Fukuoka K, Yamada A, Nagasawa T, Era S. Alteration of redox state of human serum albumin before and after hemodialysis. Blood Purif 2004; 22: 525–529
  • Hayakawa A, Kuwata K, Era S, Sogami M, Shimanaka H, Yamamoto M, Dohi S, Hirose H. Alteration of redox state of human serum albumin in patients under anesthesia and invasive surgery. J Chromatogr B 1997; 698: 27–33
  • Ali R, Dersimonian H, Stollar BD. Binding of monoclonal anti-native DNA autoantibodies to DNA of varying size and conformation. Mol Immunol 1985; 22: 1415–1422
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265–275
  • Bradford MM. A rapid and sensitive method for the quantitation microgram quantity of protein utilizing the principle of protein dye binding. Anal Biochem 1976; 72: 248–254
  • Wallevik K. Reversible denaturation of human serum albumin by pH, temperature and guanidine hydrochloride. J Biol Chem 1973; 245: 2650–2655
  • Chen YH, Yang JT, Martinez H. Determination of the secondary structure of proteins by circular dichroism and optical rotatory dispersion. Biochemistry 1972; 11: 4120–4131
  • Goding JW. Use of Staphylococcal protein-A as immunological reagent. J Immunol Methods 1978; 20: 241–254
  • Khan F, Ali A, Ali R. Enhanced recognition of hydroxyl radical modified plasmid DNA by circulating cancer antibodies. J Exp Clin Cancer Res 2005; 24: 289–296
  • Dixit K, Ali R. Role of nitric oxide modified DNA in the etiopathogenesis of systemic lupus erythematosus. Lupus 2004; 13: 95–100
  • Ali R, Alam K. Evaluation of antibodies against free radical modified DNA by ELISA. Oxidative stress biomarkers and antioxidants protocols, D Armstrong. Humana Press, New Jersey 2002; 171–181
  • Lee JY, Hirose M. Partially folded state of the disulfide-reduced form of human serum albumin as an intermediate for reversible denaturation. J Biol Chem 1992; 14753–14758
  • Ashok BT, Ali R. Aging research in India. Exp Gerontol 2003; 38: 597–603
  • Ashok BT, Ali R. Binding of human anti-DNA autoantibodies to reactive oxygen species modified DNA and probing oxidation DNA damage in cancer using monoclonal antibody. Int J Cancer 1998; 78: 404–409
  • Cheng F, Jen J, Tsai T. Hydroxyl radical in living systems and its separation methods. J Chromatogr B 2002; 781: 481–496
  • Imamura A, Hirao K. A molecular orbital approach to the electrophilicity of H and OH radical. Bull Chem Soc Jpn 1979; 52: 287–292
  • Hardin JA. The lupus autoantigens and the pathologenesis of systemic lupus erythematosus. Arthritis Rheum 1986; 29: 457–460
  • Arif Z, Ali R. Antigenicity of poly (dA–dT). Poly (dA–dT) photocrosslinked with 8-methoxypsoralen. Arch Biochem Biophys 1996; 329: 191–198
  • Moinuddin Ali A. SLE anti-DNA autoantibodies binding estradiol–albumin–DNA conjugate. Lupus 1994; 3: 43–46
  • Perl A. Pathogenesis and spectrum of autoimmunity. Autoimmunity. Methods and protocols, A Perl. Humana Press, New Jersey 2004; 1–8
  • Ravirajan CT, Rowse L, MacGowan JR, Isenberg DA. An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: A cross-section study. Rheumatology 2001; 40: 1405–1412

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.